Nantahala Capital Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1472322
New Canaan, CT
Position in BCRX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$19,011,600
+$91,581 QoQ
Shares Held
1,901,160
-4.3% QoQ
Ownership
0.744%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#32
of 316 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $169,874,929 across 9 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ETON |
Eton Pharmaceuticals, Inc.
|
1,175,951 | $42,569,426 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,268,751 | $39,272,079 | |
| 3 | EOLS |
Evolus, Inc.
|
5,602,021 | $38,878,025 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
1,901,160 | $19,011,600 | |
| 5 | ADCT |
ADC Therapeutics SA
|
12,326,184 | $13,189,016 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
486,684 | $8,740,844 | |
| 7 | TLPH |
Talphera, Inc.
|
3,492,519 | $3,597,294 | |
| 8 | AYTU |
Aytu Biopharma, Inc
|
1,086,812 | $2,336,645 |
All Filings in BCRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,011,600 | 1,901,160 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $18,920,019 | 1,987,397 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,579,740 | 1,356,377 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||